Navigation Links
The Leukemia & Lymphoma Society Awards Major Grant to Stanford Researcher
Date:9/30/2008

LLS Specialized Center of Research Program Hits $178 Million Mark

WHITE PLAINS, N.Y., Sept. 30 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today announced it has awarded a new Marshall A. Lichtman Specialized Center of Research (SCOR) grant to Beverly Mitchell, M.D., George E. Becker Professor of Medicine at Stanford University.

Dr. Mitchell and her team will receive $1.25 million a year for five years, for a total of $6.25 million. The SCOR program is LLS's largest research grant, with total funding of $178.25 million since its inception in 2000. The title of her SCOR is: Molecular and Cellular Characterization of Myelodysplastic Syndromes.

The SCOR program brings together teams of researchers representing different disciplines in collaborative efforts to discover new approaches to treat patients with leukemia, lymphoma and myeloma. Awards go to groups that best demonstrate outstanding scientific promise facilitated by the synergy that will occur from their combined efforts.

Dr. Mitchell's team is studying stem cells in myelodysplastic syndromes (MDS), a collection of related disorders in which damaged bone marrow cells can't mature into functional blood cells. The disorders frequently progress to acute myelogenous leukemia (AML). Her team has recently identified new molecular markers than can help identify the MDS stem cells that have progressed to AML, and are working to develop therapies to target these abnormal MDS stem cells. A clinical trial of an investigational drug that targets one of the enzymes involved in the development of MDS will be initiated.

"Dr. Mitchell and her team of investigators are undertaking cutting-edge research to reach a better understanding of the root causes of MDS," said Louis DeGennaro, Ph.D., LLS's chief scientific officer. "Their work will likely lead to new therapies that target these diseases. This research team is an impressive addition to the outstanding scientists already in
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. New leukemia signal could point way to better treatment, Stanford researchers find
2. The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years
3. Stater Bros. Raises $200,000 for the Leukemia & Lymphoma Society
4. Methadone Kills Resistant Leukemia Cells
5. FDA Accepts Gentas NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia
6. Leukemia drug could save lives of stroke patients
7. Math could help cure leukemia
8. Gene mutation improves leukemia drugs effect
9. Microenvironment a main driver of aggressive multi-lineage leukemia disease type
10. Clinical study shows biological and clinical activity in relapsed leukemia patients
11. Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...30 SEIU Local 21LA memb...ation Sodexo will hold a rally Tuesday, Dec. 1, 20...eadquarters, 3800 Desire Parkway, New Orleans, to ... disciplinary policies that target employees who a...r. Sodexo employees who clean schools in the Recov...
(Date:11/30/2009)... Study Uses Tent To Simulate High Altitude, Low ...re-USNewswire/ -- Distance runners who live at hig...prove their performance during races in areas that...ho suffer from fatigue, improve their exercise per...simulator? ,, That is the question being studie...
(Date:11/30/2009)..., Nov. 30 The Eject Helmet Removal...d equipment in the Top Fuel, Funny Car, Pro Stock ...al Hot Rod Association (NHRA) Full Throttle Drag R...and Top Alcohol Funny Car drivers in the NHRA Luca...uct that allows medical caregivers at race tracks ...
(Date:11/30/2009)...2009 ― Providing free medications to people ...ves at a relatively low cost for provincial govern...St. Michael,s Hospital in Toronto. , "Many pati...medications because they simply don,t fill their p...lead author and a physician at St. Michael,s Hospi...
(Date:11/30/2009)...v. 30 Reportlinker.com announces t...ts catalogue: ,, Key Players and Innovative St...ingredients, pharma, food and drinks ,, http:...novative-Start-Ups-in-Nutraceuticals-Emerging-stra... ,, Nutraceuticals are bioactive compounds with...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
... Finally, the world,s first complete intimacy kit... With all the concerns about STDs being plastered ... leave it to a company called "Safe & Cle...l 9, 2009 -- The world,s first complete intimacy k...
... 8 Today, the U.S. Food and Drug Administration (...(PDAC) conducted a review of the safety and effica...r SEROQUEL XR (quetiapine fumarate) extended-relea...: , , , SEROQUEL XR was shown to be eff...
... programs for delivering optimum value and custome...90% of the nation,s nonprofit academic medical cen...lutions, a leader in delivering healthcare resourc...ated hospitals, representing approximately 90% of ...
...predominance of heartburn among asthma sufferers l...uld be a trigger for the coughing, wheezing and br...ndard practice to prescribe heartburn medication t...l without significant heartburn shows that heartbu...
...l 8 The following was released today by the Ameri...ts have suffered a severe blow in the last week. ...s to redefine marriage and in so doing has jeopard... statement that, "The traditional notion that chil...
...nknown in adults, revs up calorie-burning, experts...s) -- Take note of the brown revolution -- the bro...ups of scientists on two continents have independe...sue is metabolically active and the more of this f...
Other Medicine News:Health News:The World's First Complete Intimacy Kit for Safe and Clean Sex 2Health News:The World's First Complete Intimacy Kit for Safe and Clean Sex 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 2Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 4Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 5Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 6Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 7Health News:University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum 2Health News:University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum 3Health News:Heartburn medications do not ease asthma symptoms 2Health News:Heartburn medications do not ease asthma symptoms 3Health News:A Fat That May Keep You Thin 2Health News:A Fat That May Keep You Thin 3
(Date:11/30/2009)...Newswire/ -- Amoena USA Corporation, the worldwide...ponsoring the 4th Annual Breast Cancer Survivors C...nor survivors and the people who helped them throu...with the most inspirational story to tell. ,, A...young mothers who bravely endured treatments; wome...
(Date:11/30/2009)..., November 30 Optoacoustics has an...nnel microphone, the most advanced,optical microph...ance imaging,(fMRI) environments. , The t...ard for fiber,optic microphone technology, providi...ncy adaptive noise cancelling. The FOMRI-III also ...
(Date:11/30/2009)... Intelliject, Inc. today announced... a novel epinephrine auto-injector, in the U.S. an...tis U.S. shall be responsible for manufacturing an...le for the on-going development and for obtaining ...co-promotion rights in the territory. ,, Sanofi...
Breaking Medicine Technology:Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Prix Galien USA Announces 2009 Final Candidates 13441 1Prix Galien USA Announces 2009 Final Candidates 13441 2Cleveland Joins Navvis 26amp 3B Company 53927 1Cleveland Joins Navvis 26amp 3B Company 53927 2Guided care reduces cost of health care for older persons with chronic conditions 53925 1Guided care reduces cost of health care for older persons with chronic conditions 53925 2
...ia Pharmaceuticals presented,positive results toda...onal,HIV protease inhibitor (PI). One study based ... of interaction of SPI-256 with HIV protease,provi...tic barrier to,resistance. The second study conduc...6 is generally safe and well tolerated in humans a...
...harmaceuticals, Inc. today,announced positive Phas...96, a first-in-class aminomethylcycline (AMC). The...l and intravenous (IV) forms of PTK 0796 to,Zyvox(...kin and skin,structure infections (cSSSIs). Parate...endpoint, demonstrating no differences between PTK...
Other Medicine Technology:Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 2Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 3Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 4Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4
... CIC are formed as a host defense against foreign ...If not cleared, CIC may be deposited in tissue and...in Systemic Lupus Erythematosus (SLE), Rheumatoid ...mune disorders as well as in infectious and neopla...
Microalbumin Linearity Control
Lyophilized Lipid Control
ASO / RF / CRP Control
Medicine Products: